Skip to main content
. 2010 Aug;31(7):1178–1180. doi: 10.3174/ajnr.A2142

Fig 1.

Fig 1.

Schematic illustration of the mechanism of action of rituximab. The antibody labels B lymphocytes, which have the CD20 cell marker. These cells are then killed by 1 of 3 mechanisms: antibody-dependent cytotoxicity, complement-dependent cytotoxicity, or stimulation of apoptosis. Illustration by Priya A. Rajdev.